Biophysical Sorting of Culture-Expanded MSCs for Osteogenic Potential
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing large quantities of uniform and therapeutically effective bone marrow-derived mesenchymal stem/stromal cells (MSCs) for regenerative purposes are inadequate, as they fail to consistently produce cells with enhanced regenerative potential and uniform properties.
Innovation Solution
A method involving culturing MSCs to a confluence of 80-90% over four population doublings, followed by biophysical sorting to isolate large-MSCs with enhanced regenerative potential, which are then cryopreserved for therapeutic use, enhancing their osteogenic activity and homing capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If MSCs are cultured to high confluence over multiple population doublings to expand cell quantity, then large quantities of cells are produced, but the uniformity and regenerative potency of the cell population deteriorates due to heterogeneity development
Solution Approach 1:
The patent applies preliminary action by establishing specific culture conditions (confluence of 70-90% over 3-6 population doublings) before the cell population becomes too heterogeneous. This timing-based intervention captures cells at the optimal stage for regenerative potency while preventing the development of significant heterogeneity that would occur with extended culturing.
Solution Approach 2:
The patent utilizes parameter changes by defining precise culture parameters (confluence range of 70-90%, number of population doublings of 3-6, seeding density of 1000 MSCs/cm²) that control the balance between cell expansion and maintenance of uniformity. These parameter specifications ensure cells are harvested at the optimal point before heterogeneity develops.
2Quantity of substance
If conventional MSC culture methods are used to produce large quantities of cells, then cell availability increases, but the regenerative potential and therapeutic efficacy deteriorate due to loss of osteogenic activity
Solution Approach 1:
The patent applies parameter changes by optimizing culture conditions to maintain osteogenic markers (alkaline phosphatase activity, osteopontin expression) during expansion. Specific parameters include culturing to 70-90% confluence over 3-6 population doublings with seeding density of 1000 MSCs/cm², which preserves regenerative potential while achieving sufficient cell quantities for therapy.
Solution Approach 2:
The patent replaces conventional mechanical passaging methods with biophysical sorting based on cell size. This substitution allows separation of osteoprogenitor cells (larger cells) from other MSCs without the stress of enzymatic treatment, thereby maintaining cell potency and regenerative capabilities while achieving pure populations.
3Productivity
If MSC populations are expanded extensively in culture, then sufficient cell numbers for therapy are achieved, but the potency and therapeutic properties deteriorate due to phenotypic drift and heterogeneity
Solution Approach 1:
The patent applies preliminary action by establishing a standardized culture protocol that limits expansion to 3-6 population doublings to 70-90% confluence. This preliminary framework prevents excessive expansion before heterogeneity becomes problematic, ensuring cells are processed at the optimal stage for therapeutic consistency.
Solution Approach 2:
The patent replaces conventional culture-based separation with biophysical sorting by cell size. This mechanical substitution enables precise isolation of osteoprogenitor cells based on their larger size, achieving uniform therapeutic populations without relying on extended culture periods that would cause phenotypic drift.
4Reliability
If biophysical sorting is applied to isolate large-MSCs from culture-expanded populations, then regenerative potential is enhanced, but the complexity of the production process increases
Solution Approach 1:
The patent applies mechanics substitution by replacing complex biochemical sorting methods with simple biophysical sorting based on cell size. This approach uses the inherent physical difference (larger size of osteoprogenitor cells) to achieve separation through straightforward filtration or flow-based methods, reducing process complexity while enhancing regenerative potential.
Solution Approach 2:
The patent utilizes parameter changes by focusing on a single physical parameter (cell size) for sorting rather than multiple biochemical markers. This simplification of the sorting criterion reduces process complexity while effectively isolating the regenerative cell population based on their characteristic larger dimensions.
Data Source
Figure 1A~1C
Figure 1D~1E
Figure 1F
AI summary
The invention provides, inter alia, populations of large mesenchymal stem cells (MSC)(as well as conditioned medium from these cells) with enhanced regenerative potential, as well as methods of culturing and using these populations, such as therapeutic methods of mediating tissue repair or enhancing homing and engraftment of hematopoietic stem cells. These large MSC populations can, in certain embodiments, be produced by biophysically sorting an MSC-containing population.